Efficacy and acceptability of perindopril in mild to moderate chronic congestive heart failure
- 30 September 1993
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 126 (3) , 798-806
- https://doi.org/10.1016/0002-8703(93)90933-z
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Systemic and Regional Hemodynamic Effects of Perindopril in Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1990
- Influence of age on the pharmacokinetics and pharmacodynamics of perindoprilClinical Pharmacology & Therapeutics, 1988
- Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man.British Journal of Clinical Pharmacology, 1987
- Single and repeated dosing of the converting enzyme inhibitor perindopril to normal subjectsClinical Pharmacology & Therapeutics, 1986
- Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failureJournal of the American College of Cardiology, 1985
- Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.Circulation, 1984
- A placebo-controlled trial of captopril in refractory chronic congestive heart failureJournal of the American College of Cardiology, 1983
- Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.Circulation, 1981
- Angiotensin inhibition in severe heart failure: Acute central and limb hemodynamic effects of captopril with observations on sustained oral therapyAmerican Heart Journal, 1981
- Treadmill exercise in assessment of the functional capacity of patients with cardiac diseaseThe American Journal of Cardiology, 1972